Stay updated on EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).
    Difference
    12%
    Check dated 2025-10-06T06:52:55.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.
    Difference
    0.3%
    Check dated 2025-09-29T03:29:41.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Updated revision from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.
    Difference
    0.7%
    Check dated 2025-09-14T21:37:09.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.7%
    Check dated 2025-09-07T17:55:11.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms have been removed.
    Difference
    13%
    Check dated 2025-08-31T12:20:09.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-17T04:44:31.000Z thumbnail image

Stay in the know with updates to EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.